Market Size (2018)
2018
$2.11B
Healthcare
Biopsy Device Market
By Segment, By Region, And Segment Forecasts, 2018 – 2030
Vertical: HealthcareBase Year: 202112 Sections
Executive Summary
Biopsy Device Market — Snapshot
Projected (2030)
2030
$4.23B
CAGR (2018–2030)
5.9%
5.9%Key Players
111+
This report covers Biopsy Device Market with forecasts from 2018 to 2030. 111 key companies are profiled.
Key Insight
The Biopsy Device Market market is projected to grow at a CAGR of 5.9% from 2018 to 2030.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 4 regions: North America, Europe, Asia Pacific, Rest of the World.
- Market Segmentation: The market is analyzed across key segments with forecasts from 2018 to 2030.
- Competitive Landscape: 111 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Biopsy Device Market — Growth Trajectory
A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologist. The process involves extraction of sample cells or tissues for examination to determine the presence or extent of a disease. The tissue is then fixed, dehydrated, embedded, sectioned, stained and mounted before it is generally examined under a microscope by a pathologist; it may also be analyzed chemically.
Market Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- BY Product Type BY Product Type is broken down into: Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others.
- By Biopsy Needles By Biopsy Needles is broken down into: Vacuum-Assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices, Core Needle Biopsy (CNB) Devices.
- By Application By Application is broken down into: Brest Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynacological Biopsy, By Application_Others.
- By Guidance Technique By Guidance Technique is broken down into: Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, By Guidance Technique_Others.
- By End User By End User is broken down into: Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, By End User_Others.
Geographic Analysis
Regional market breakdown
- North America North America market size reached $811.40M in 2018 and is projected to reach $1.55B by 2030, growing at a CAGR of 5.6%.
- Europe Europe market size reached $551.50M in 2018 and is projected to reach $1.08B by 2030, growing at a CAGR of 5.7%.
- Asia Pacific Asia Pacific market size reached $547.30M in 2018 and is projected to reach $1.25B by 2030, growing at a CAGR of 7.1%.
- Rest of the World Rest of the World market size reached $202.80M in 2018 and is projected to reach $349.90M by 2030, growing at a CAGR of 4.7%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Biopsy Device Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2021
Historical Period
2018 – 2021
Forecast Period
2021 – 2030
Primary Interviews
150+
Research Process
Historical data (2018–2021) and forecast period (2021–2030)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
Biopsy Device Market — Competitive Analysis
Threat Of New Entrants
The threat of new entrants in the biopsy devices market is moderate. Any company manufacturing biopsy devices is required to accept and abide by the mandatory regulatory standards set by the respective regulatory authorities of a country, such as the United States Food and Drug Administration (FDA), European Medicines Agency (EMA), The Central Drugs Standard Control Organization (CDSCO), and others. However, huge opportunities in the market have encouraged many players to invest in this lucrative market. Moreover, supportive government policies and a rising number of investors have impulse entrepreneurs to enter the handheld surgical device industry. These factors are responsible for minimizing the entry barriers for new players, which can be a major threat to the current companies.
Bargaining Power of Suppliers
The global biopsy devices market suppliers are the developers and manufacturers of biopsy devices such as forceps, retractors, graspers, and others used in various general surgical procedures. The bargaining power of suppliers is a crucial factor in the biopsy devices market and determines the industry's strength. Many suppliers are currently present in the market due to the high demand for biopsy devices and increasing government support. The existing key companies capture significant market share and monitor the costs of biopsy devices. The switching cost of these suppliers is moderate because suppliers tend to enter long-term associations, partnerships, and deals with other handheld surgical device manufacturing companies. Thus, the overall bargaining power of suppliers in the global biopsy devices market is expected to be moderate during the forecast period.
Threat of Substitutes
Biopsy devices are reliable, cost-effective products such as scalpels, forceps, retractors, and others used in various general surgical procedures. Furthermore, many large and medium-scale companies manufacture different types of products for different application. Some small companies provide their products at low prices to sustain themselves in this highly competitive market. Thus, the overall threat of substitutes in the global biopsy devices market is expected to be moderate-to-low during the forecast period.
Bargaining Power of Buyers
The global biopsy devices market is characterized by the presence of a large number of buyers. The market for biopsy devices is identified as having a significant customer base, considering the increasing number of patients suffering from chronic diseases and the increasing use of products for various biopsy procedures. However, the buyers tend to use the products that have been provided by the top players irrespective of the pricing. Thus, the bargaining power of buyers is expected to be moderate in the global biopsy devices market during the forecast period.
Intensity of Rivalry
The overall degree of competition in the global biopsy devices market is high. The reserved degree of product differentiation among existing players increases the intensity of rivalry in the market. The companies engaged in manufacturing biopsy devices are developing advanced products for differentiating their brand from the competitors. Additionally, many prominent market players are entering into strategic partnerships, co-development activities, and tie-ups with established companies to overcome the competition. Thus, the intensity of rivalry in the global biopsy devices market is expected to be high during the study period.
Quantitative Analysis
Regional Breakdown
Regional market breakdown for Biopsy Device Market.
Regional Market Size (USD Mn)
Market estimates by geography (2030)
USD Mn
InsightNorth America leads with $1.55B by 2030, while Asia Pacific is projected to grow fastest at a 7.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2018 | 2021 | 2030 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $811.40M | $1.05B | $1.55B | 5.6% | 37% |
| Europe | $551.50M | $720.30M | $1.08B | 5.7% | 26% |
| Asia Pacific | $547.30M | $773.40M | $1.25B | 7.1% | 29% |
| Rest of the World | $202.80M | $249.60M | $349.90M | 4.7% | 8% |
| Total | $2.11B | $2.79B | $4.23B | 5.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Biopsy Device Market — Key Findings
Analytical insights on Biopsy Device Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The Biopsy Device Market market is projected to reach $4.23B by 2030, growing at 5.9% CAGR.
Market Drivers
A biopsy is a type of diagnostic procedure used to find both malignant and non-cancerous abnormalities in the human body. The global market for biopsy devices is projected to expand due to the rising incidence of cancer in the population. For instance, cancer is the second-leading cause of death in the US after heart disease and is the primary cause of death in Canada. According to the American Cancer Society, there were 693,000 cancer fatalities and 1.9 million new cancer diagnoses in 2018. In North America, prostate cancer is the disease that is most frequently diagnosed in men, but breast cancer continues to be the most common cancer in women. Lung cancer continues to be the leading cause of death in both sexes. The National Health Profile reports that from 2017 to 2018, there was a 324% increase in the incidence of common malignancies in India, including breast, oral, and cervical cancer. Additionally, in 2017 and 2018, the overall number of patients visiting Non-Communicable Diseases (NCD) clinics doubled to 35 million and 66 million, respectively. One of the main causes of the population's cancer incidences rising is the rapid change in lifestyle, as well as the intake of alcohol and cigarette products. Boston Scientific Corporation, BD, Qiagen, F.Hoffmann La-Roche Ltd., Hologic, and other significant manufacturers of biopsy instruments and related products for the diagnosis of cancer and other disorders. Hence, it is anticipated that the global market for biopsy instruments will expand due to the rising incidence of cancer worldwide.
Market Opportunities
Robotic-assisted biopsy technologies are reshaping the market for biopsy devices and reducing post- biopsy consequences. Medical authorities have been approving the gadgets to make the process simpler, and robot-assisted biopsy is done to improve the precision and accuracy of the biopsy process. For instance, the platforms developed by Siemens Healthineers and Intuitive to create a robotic-assisted platform for minimally invasive lung biopsies were approved by the FDA in July 2022. During processes, the integration would enable 2D and 3D images. A US-based manufacturer of medical devices called MEDTRONIC PLC. purchased Digital Surgery in February 2020 for an undisclosed sum. The acquisition would increase Medtronic’s portfolio and strengthen its robot- assisted surgical platform. Robotic surgery and surgical artificial intelligence are the specialties of London-based Digital Surgery.
Market Restraints
Adoption of biopsy devices may be hampered by a lack of healthcare infrastructure, particularly in low- and middle-income nations. Radiologists, pathologists, and oncologists, among others, are necessary for biopsy operations but may not be accessible in all locations. The deployment of biopsy devices may be constrained by the lack of qualified medical personnel, which could lead to improper or delayed treatment. Also, there may not be widespread access to medical facilities with the necessary equipment for biopsy procedures in many low- and middle-income nations. This may make it challenging for people to get the care they require and may delay a diagnosis or course of therapy. Healthcare providers may find it challenging to invest in innovative technologies, such as biopsy instruments, in some nations due to a lack of funding for the sector. This may prevent biopsy equipment from being widely used and lead to patients obtaining subpar care.
Market Challenges
The market for biopsy device is predicted to grow slowly due to the increase in problems related to biopsies. Excessive bleeding, infection, puncture damage to neighbouring organ tissue, and skin numbness near the biopsy site are complications that might arise from a biopsy. Sometimes insufficient materials are gathered, necessitating a repeat of the procedure. Major bleeding after a percutaneous native kidney biopsy occurred in about 4.3% of cases, according to research that was published in January 2020. The expansion of the market is impacted by these issues in biopsy procedures.
Strategic Outlook and Future Directions
The COVID-19 outbreak, which started in China, has had a major impact on the global economy. The outbreak has impacted the global economy in several ways, including industries such as oil & gas, manufacturing, energy, chemicals, and pharmaceuticals. This pandemic has not only caused disruptions in the supply chains of the industrial sector but also influenced the purchasing decisions and spending behavior of the end users. Moreover, the industrial sector has been severely affected as most countries worldwide have imposed lockdown restrictions, which have not only impacted the import & export of goods & services but has also declined the sales of products in the domestic market.
Furthermore, industries such as electrical and electronics, oil & gas, and manufacturing, among others, have either stopped operations completely or have reduced their workforce due to the pandemic and safety of the employees, which has drastically impacted the biopsy devices market. Most companies in the biopsy devices business have seized operations to ensure the safety of employees. However, some companies are operating at minimum capacity to support essential industries.
Impact on the Global Biopsy Devices Market
The pandemic has impacted the biopsy devices market globally. As many businesses came to a halt in the first quarter of FY’2020, manufacturing plants cut output due to declining demand. Furthermore, the biopsy devices producers had to shut down their operations in a few parts of the country due to less demand. Additionally, manufacturers have also been impacted as all the major industries have attempted to contain the virus by shutting down their businesses. These factors have impacted the biopsy devices market globally. On the other hand, the US, China, India, and other key markets in Europe have also witnessed a greater impact on the manufacturing industry due to the global pandemic and the shutdown of manufacturing plants. The demand for biopsy devices across end users has decreased drastically due to the halt in production sites because of COVID-19.
Impact on Supply Chain of Biopsy Devices Market
The pandemic has affected the economic environment for a number of businesses around the world. The supply chain in the global market is the key to fulfilling customer demands. As a result of the COVID-19 pandemic, several countries-imposed import and export restrictions. This has also impacted the healthcare industry as many countries rely on other countries for raw material supply. Raw materials required for manufacturing biopsy devices had a shortage due to trade barriers that hampered the market. COVID-19 significantly disrupted the biopsy devices industry in 2020, as the production and supply chain of biopsy devices has been restricted due to the lockdowns. Additionally, due to a change in healthcare priorities and as a precautionary measure to constrain the spread of the COVID-19 virus, several surgeries and procedures were postponed. This led to a significant backlog in the number of surgical procedures performed, thereby affecting the market negatively. In addition, several ambulatory surgical centers had to be shut down due to the huge losses that they had to incur as a result of the COVID-19 pandemic. However, in 2021, hospitals and other settings started performing surgical procedures in full volume and it has helped the market to recover. Significant backlogs in surgical procedures and increasing demand for elective surgeries are further expected to surge the demand for the biopsy devices market.
Impact on Pricing Biopsy Devices Market
Biopsy Devices are likely to witness lucrative growth through an anticipated recovery of prices and strategic measures taken by the companies operating in the upstream sector to increase the E&P activities. The ongoing investments by the major players in the industry to enhance biopsy devices is projected to enhance the prices of biopsy devices.
Impact on Key Players
The main target for the companies in this COVID-19 situation would be to provide products to the client base at a minimal price or at least with the same pricing for biopsy devices. This may come as a challenge for the market players as their expenditures are allegedly rising, owing to the COVID-19 pandemic, as sanitization & hygiene standards in the organization, additional benefits are given to the employees keeping in mind the pandemic situation and others increasing the cost. Moreover, due to stricter lockdown measures in several countries, many companies have shifted temporarily to remote working, which has hampered their services.
Companies
Key companies profiled in Biopsy Device Market
Profiles of 111 companies operating in the Biopsy Device Market market, including revenue, employee count, and market positioning where available.
Showing 111 of 111 companies
Trivitron
Trivitron Healthcare
Healthcare
Company Headquarters: India Founded: 1977 Workforce: 1,000 Company Working: Trivitron Healthcare is a leading Indian medical technology company that provides medical devices, equipment, and services across multiple specialties, including radiology, critical care, pathology, and cardiology. The company was founded in 1997 and is headquartered in Chennai, India. Trivitron Healthcare's portfolio of products includes diagnostic imaging systems, radiation oncology products, laboratory diagnostics, anesthesia, and critical care products, and a range of other medical equipment and services. The company has a strong presence in both the Indian and global markets, with offices and subsidiaries in more than 165 countries. The company’s breast Biopsy Systems provide the most comprehensive and personalised solution for all breast healthcare requirements. This procedure is used to remove tissues or fluids from suspicious areas. These removed cells are then tested for the presence of breast cancer. This diagnostic procedure can determine whether or not the suspicious area is cancerous. Trivitron's portfolio as a breast biopsy system supplier includes everything from imaging equipment and breast biopsy devices to guidance systems, analysis software, and site markers, all of which are designed to work together.
RevenueN/A
Employees1,000
Market CapN/A
Founded1976
India
INRAD Inc
INRAD Inc
Healthcare
Company Headquarters: US Founded: 1981 Workforce: 11-50 Company Working: INRAD Inc. is a medical device company that specializes in the development, manufacturing, and marketing of medical imaging equipment and accessories for use in interventional radiology, breast biopsy, and radiation oncology. The company is headquartered in Moscow, Idaho, USA. INRAD Inc. has been involved in the development of breast biopsy systems since the early 1980s. The company offers a range of breast biopsy devices.
RevenueN/A
Employees50
Market CapN/A
Founded1980
US
Mammotome
Mammotome
Healthcare
Company Headquarters: US Founded: 1995 Workforce: 750 Company Working: Mammotome’s parent organization is Danaher Corporation. Mammotome is a brand of breast biopsy devices. The companys biopsy devices are recognized for their accuracy, efficiency, and patient comfort, and are widely adopted by healthcare professionals around the world. The company's product portfolio includes the Mammotome Revolve and Mammotome Elite devices, which are designed for both stereotactic and ultrasound-guided breast biopsy procedures. The Mammotome brand of products is sold in over 50 different countries throughout the world.
RevenueN/A
Employees750
Market CapN/A
Founded1994
US
Integra Li
Integra Life Sciences
Healthcare
Company Headquarters: US Founded: 1989 Workforce: 4,700 Company Working: Integra Life Sciences is a leading global medical technology company that specializes in developing, manufacturing, and marketing innovative products and solutions to meet the needs of surgeons, healthcare professionals, and patients worldwide. Integra products are sold in over 130 countries via a direct sales force, distributors, and wholesalers. Codman Specialty Surgical ("CSS") and Tissue Technologies ("TT") are the two reportable business segments in which company manufacture and sell medical technologies and products. The CSS segment, which accounts for two-thirds of our total revenue, consists of market-leading technologies and instrumentation used in a variety of specialties, including neurosurgery, neurocritical care, and otolaryngology.
Revenue$1.5B
Employees4,700
Market CapN/A
Founded1988
US
Cardinal H
Cardinal Health Inc
Healthcare
Company Headquarters: US Founded: 1971 Workforce: 46,500 Company Working: Cardinal Health Inc. is a global healthcare services and products company headquartered in Dublin, Ohio. The company operates through two main business segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, and consumer products to pharmacies, hospitals, and other healthcare providers. The Medical segment supplies medical products and services to healthcare providers, including medical-surgical products, laboratory products, and ambulatory care services. Cardinal Health Inc. offers a wide range of medical devices, including biopsy devices. Biopsy devices are used to collect tissue or cell samples for analysis to diagnose or monitor medical conditions, such as cancer. Cardinal Health Inc. offers a variety of biopsy devices, including those for breast biopsies, bone biopsies, and soft tissue biopsies. Their biopsy devices are designed to be safe, efficient, and precise, with features such as adjustable penetration depth and real-time imaging guidance. Cardinal Health Inc. is a global company with operations in over 60 countries worldwide
Revenue$152.9B
Employees46,500
Market CapN/A
Founded1970
US
BD
BD
Healthcare
Company Headquarters: US Founded: 1897 Workforce: 77,000 Company Working: BD (Becton, Dickinson and Company) is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents. BD is a leading global medical technology company that is committed to advancing the world of health. The company operates in three main segments: BD Medical, BD Life Sciences, and BD Interventional. Its products and services are used in a wide range of medical settings, including hospitals, clinics, and research laboratories. BD's product portfolio includes a wide range of medical devices and instrument systems, including syringes, needles, catheters, diagnostic tests, and imaging systems. The company is also a leader in the development of healthcare software and data analytics solutions. BD's breast biopsy products are designed to improve the accuracy, speed, and safety of breast biopsy procedures, ultimately leading to better patient outcomes. BD has a significant global presence, with operations in over 190 countries around the world.
Revenue$16.1B
Employees77,000
Market CapN/A
Founded1896
US
Page 1 of 19
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Biopsy Device Market
Starting from
$4,950